Page last updated: 2024-11-04

sibutramine and Recrudescence

sibutramine has been researched along with Recrudescence in 3 studies

sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride

Research Excerpts

ExcerptRelevanceReference
"To develop statistical models for predicting weight loss and regain, we analyzed the phenotypic responses in an outpatient study of 60 obese subjects randomized to one of three 12-week interventions, diet (-600 kcal) alone, diet with exercise, and diet with sibutramine."5.16Prediction of weight loss and regain following dietary, lifestyle, and pharmacologic intervention. ( Brooke, A; Delafont, B; Elkhawad, M; Miller, SR; Murgatroyd, PR; Napolitano, A; Nunez, DJ; Tan, CY; Vidal-Puig, A; Virtue, S, 2012)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Naik, S1
Khoo, CL1
Lua, R1
Chai, SB1
Liew, A1
Sim, K1
Napolitano, A1
Miller, SR1
Murgatroyd, PR1
Delafont, B1
Brooke, A1
Elkhawad, M1
Tan, CY1
Virtue, S1
Vidal-Puig, A1
Nunez, DJ1
Fernández, P1
Peiró, AM1

Trials

1 trial available for sibutramine and Recrudescence

ArticleYear
Prediction of weight loss and regain following dietary, lifestyle, and pharmacologic intervention.
    Clinical pharmacology and therapeutics, 2012, Volume: 91, Issue:6

    Topics: Absorptiometry, Photon; Adult; Appetite Depressants; Body Composition; Body Weight; Calorimetry, Ind

2012

Other Studies

2 other studies available for sibutramine and Recrudescence

ArticleYear
Recurrent episodes of brief affective psychosis induced by sibutramine.
    Progress in neuro-psychopharmacology & biological psychiatry, 2010, Oct-01, Volume: 34, Issue:7

    Topics: Adult; Affective Disorders, Psychotic; Antidepressive Agents; Cyclobutanes; Female; Humans; Recurren

2010
A sibutramine-induced delusional disorder relapse.
    The Journal of neuropsychiatry and clinical neurosciences, 2007,Winter, Volume: 19, Issue:1

    Topics: Anti-Obesity Agents; Cyclobutanes; Delirium; Humans; Male; Middle Aged; Obesity; Recurrence; Schizop

2007